Related Experiment Video
Updated: Dec 8, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.2K
Diabetes management in hospital.
Vnitrni Lekarstvi
|September 18, 2020
Summary
Hospitalized patients with diabetes require specialized care. This article provides essential recommendations for managing diabetes treatment during hospital stays, simplifying care for these complex patients.
Area of Science:
- Internal Medicine
- Endocrinology
- Hospital Management
Background:
- Diabetes mellitus affects approximately 25% of individuals admitted to hospitals.
- Managing diabetes in hospitalized patients presents unique challenges, often complicating standard medical care.
- Adjusting or initiating antidiabetic therapies requires careful consideration on general medical wards.
Purpose of the Study:
- To outline fundamental guidelines for the treatment of diabetes in hospitalized patients.
- To provide a practical framework for healthcare professionals managing diabetic inpatients.
- To address the complexities of inpatient diabetes management and improve patient outcomes.
Main Methods:
- Review of current clinical practices and guidelines for inpatient diabetes management.
- Synthesis of evidence-based recommendations for antidiabetic treatment adjustments.
- Development of a simplified approach to inpatient diabetes care.
Main Results:
- Identification of key challenges in modifying diabetes treatment during hospitalization.
- Establishment of core principles for effective inpatient diabetes management.
- Provision of actionable recommendations for initiating and adjusting antidiabetic medications.
Conclusions:
- Standard medical wards require specific strategies for optimal diabetes treatment.
- Clear recommendations can facilitate better management of diabetic inpatients.
- Improved inpatient diabetes care is crucial for patient safety and recovery.
More Related Videos
Related Concept Videos
Diabetes: Management and Pharmacotherapy
762
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
762
Diabetes Mellitus: Type 2 and Gestational
4.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Diabetes Mellitus: Overview and Type I Subtype
4.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.6K
Hypoglycemia and Glucagon
665
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
665
Insulin: Dosing Regimen and Adverse Effects
527
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
527
Diabetes: Symptoms, Diagnosis, and Complications
1.8K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.8K

